欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/0165/004
药品名称Prograf
活性成分
    • TACROLIMUS ANHYDROUS 5.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Astellas Pharma Co. Ltd. 5 Waterside Citywest Business Campus Naas Road Dublin 24 Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Slovenia (SI)
    • Belgium (BE)
    • Malta (MT)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
    • Germany (DE)
    • Slovakia (SK)
    • Denmark (DK)
许可日期2008/04/05
最近更新日期2024/11/22
药物ATC编码
    • L04AA05 Tacrolimus
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase